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Objectives.Toreviewoursedationpracticeandtoevaluatetheclinicaleﬀectivenessofananesthesiologist-administeredintravenous
sedation outside of the main operating room for pediatric upper gastrointestinal endoscopy (UGIE) in Thailand. Subjects and
Methods. We undertook a retrospective review of the sedation service records of pediatric patients who underwent UGIE. All
endoscopies were performed by a pediatric gastroenterologist. All sedation was administered by staﬀ anesthesiologist or anesthetic
personnel. Results. A total of 168 patients (94 boys and 74 girls), with age from 4 months to 12 years, underwent 176 UGIE
procedures. Of these, 142 UGIE procedures were performed with intravenous sedation (IVS). The mean sedation time was
23.2 ± 10.0 minutes. Propofol was the most common sedative drugs used. Mean dose of propofol, midazolam and fentanyl
was 10.0 ± 7.5mg/kg/hr ,0.2 ± 0.2mg/kg/hr ,and2.5 ± 1.2mcg/kg/hr, respectively. Complications relatively occurred frequently.
All sedations were successful. However, two patients became more deeply than intended and required unplanned endotracheal
intubation. Conclusion. The study shows the clinical eﬀectiveness of an anesthesiologist-administered IVS outside of the main
operating room for pediatric UGIE in Thailand. All complications are relatively high. We recommend the use of more sensitive
equipments such as end tidal CO2 and carefully select more appropriate patients.
1.Introduction
With the availability of newer and smaller endoscopes, the
utilization of endoscopy to diagnose gastrointestinal disor-
dersinchildrenisincreasing.Pediatricuppergastrointestinal
endoscopy (UGIE) can be completed without sedation, by
using intravenous sedation, or with general anesthesia [1–4].
However, the ideal method for sedating children for UGIE
remains controversial.
Various medication combinations have been used for
pediatric sedation, including intravenous ketamine, propo-
fol, midazolam, fentanyl, and pethidine [2]. The standard
sedation practice at our institution dependeds on the staﬀ
anesthesiologist. The goals of sedation are to ensure patient
safety, provide analgesia and amnesia, control behavior
during the procedure, enable successful completion of the
procedure, and quickly return the patient to pretreatment
level of consciousness.
In a developing country like Thailand, pediatric UGIE
is being performed at increasing rate [5–7]. In addition,
in provincial or community hospitals, general anesthesia
in the main operating room remains the sedation plan
of choice for pediatric UGIE. At Siriraj hospital, a World
Gastroenterology Organization (WGO) Endoscopy Training
Center, there is a dedicated gastrointestinal endoscopy unit
and dedicated anesthesiology service for the unit. Over
the years, we have observed a change in the trend of
sedation for pediatric UGIE towards intravenous sedation2 International Journal of Pediatrics
(IVS) technique [5–7]. This study, therefore, is done to
review our sedation practice and to evaluate the clinical
eﬀectivenessofananesthesiologist-administeredintravenous
sedation outside of the main operating room for pediatric
upper gastrointestinal endoscopy in Thailand.
2.SubjectsandMethods
This retrospective study was approved by the Institutional
Review Board of the Faculty of Medicine Siriraj Hospital,
Mahidol University. All pediatric patients scheduled for
UGIE procedures consecutively from March 2006 to October
2009 at the WGO Endoscopy Training Center in Siriraj
Hospital were included. Due to hospital policy, all children
undergoing GIE were admitted prior to the procedure. All
patients who underwent UGIE procedures with IVS were
included for analysis. Exclusion criteria were the patients
who had hemodynamic instabilities and the patients who
neededendotrachealintubation.AllsedationsforUGIEwere
clinically titrated to either moderate or deep sedation as
deﬁned according to American Academy of Pediatrics and
American Academy of Pediatric Dentistry [4].
For all patients who underwent IVS, appropriate mon-
itoring was used. Cardiovascular monitoring included con-
tinuous electrocardiogram, heart rate, oxygen saturation
measurements and ﬁve-minute interval noninvasive blood
pressure measurements from blood pressure cuﬀ device. All
patients received supplemental oxygenation at 2L/minute
through nasal canula. Ventilation monitoring included con-
tinuous respiratory rate measurements and interval observa-
tion of patterns of respiration, chest movement, and signs
and symptoms of airway obstruction. Level of consciousness
was also periodically assessed. End-tidal carbon dioxide
(CO2) monitoring with capnography or precordial stetho-
scope was not used during sedation.
The following data was obtained: age, gender, weight,
ASA physical status, indications, presedation problems,
successful completion of the procedure, sedation time,
type of intervention, and sedative agents. The presedation
problems were deﬁned as the underlying diseases such as
cardiovascular disease, hematologic disease and liver disease.
The eﬀectiveness of intravenous sedation was deﬁned as
successful completion of the procedure at the target sedation
level as intended. The secondary outcome variables were
complications during and immediately after the proce-
dure. Complications were recorded including: hypotension
(deﬁnedasadecreaseofbloodpressureby20%frombaseline
and below normal for age), hypertension (deﬁned as an
increase of blood pressure by 20% from baseline and above
normal for age), bradycardia (deﬁned as a decrease in heart
rate by 30% from baseline and below normal for age),
and hypoxia (deﬁned as oxygen desaturation with SpO2 <
90%). Serious complication is any adverse event not easily
treated or managed with medication and/or maintenance
of the patient’s airway resulting in endotracheal intubation
including apnea and/or laryngospasm.
Results with variable data were expressed as mean ± SD.
Results with categorical data were expressed as percentage
(%). Comparison of adverse events by ASA physical status
or diﬀerent medication groups was done by using Student
t-test. The statistical software package SPSS for Window
Version 11 (SPSS Inc., Chicago, IL) was used to analyze the
data. A signiﬁcance level of 5% was used throughout the
study.
3. Results
During the study period, a total of 168 patients (94
boys and 74 girls), with age ranging from 4 months to
12 years, underwent 176 GIE procedures with IVS. Of
these, 26 UGIE procedures were performed with general
anesthesia (GA), and 142 UGIE procedures were performed
with intravenous sedation (IVS) and reviewed. All sedation
was given by a staﬀ anesthesiologist or the anesthetic
personnel directly supervised by a staﬀ anesthesiologist
physically present in the endoscopy room. Anesthetic per-
sonnel included second-year residents in the Anesthesiology
residency program and anesthetic nurses who are well-
trained in general anesthesia, intravenous sedation, airway
management including intubation, and cardiopulmonary
resuscitation. There were no premedications prior to the
procedure. A single anesthesiologist sedated or supervised
the sedation of the patients throughout the study. The equip-
ment used for the procedures included appropriate standard
pediatric endoscopes, depending on patient age and size.
All endoscopic procedures were performed by a pediatric
gastroenterologist.
Patient characteristics, duration of sedation, indication
of procedure, and the type of interventions are listed in
Table 1. Hematologic disease, mild to moderate ane-
mia (40.1%), liver disease, cirrhosis, portal hypertension
(37.9%), and electrolyte imbalances, hypo/hyperkalemia
and/orhyponatremia(12.4%)werethemostcommonprese-
dation problems. A total of 142 procedures, anesthesiology
residents involved in 74 procedures (52.1%), and anesthetic
nurses involved in 68 procedures (47.9%).
Table 2 showed the intravenous sedative agents used by
age and ASA physical status. Propofol was the most common
sedativedrugsusedinallageandASAphysicalstatusgroups.
Mean dose of propofol (mg/kg) used in all age groups was
signiﬁcantly diﬀerent (P = .032). However, mean dose of
propofol (mg/kg) used in both ASA physical groups was
not signiﬁcantly diﬀerent (P = .365). Additionally, mean
doseoffentanyl(mcg/kg),midazolam(mg/kg)andketamine
(mg/kg) in all age and ASA physical status groups was not
signiﬁcantly diﬀerent. However, the number of fentanyl used
in the 0–2.99 years-old group (60.0%) was relatively lower
than in the other groups (86.5% and 87.5%). Nevertheless,
the number of ketamine used in the 0–2.99 years-old group
(75.0%) was signiﬁcantly higher than in the other groups
(39.2% and 16.7%). According to ASA physical status, there
were no signiﬁcant diﬀerences in the number of propofol,
fentanyl, midazolam and ketamine used.
Therewerenofailuresofsedation. However,twopatients
became more deeply than intended and required unplanned
endotracheal intubation. These two patients were 5-monthInternational Journal of Pediatrics 3
Table 1: Patient characteristics, duration of sedation, and indica-
tion of procedure.
Variable Overall (n = 142)
Age (yr) (mean, SD; range) 7.2 (3.7); 0.04–12.0
Gender (Male/Female; %) 80/62 (56.3/43.7)
Weight (kg) (mean, SD; range) 23.5 (11.3); 2.7–55
ASA physical status (I/II/III/IV; %) 43/47/50/2
(30.3/33.1/35.2/1.4)
Duration of sedation (min)
(mean, SD; range)
23.2 (10.0);
5.0–60.0
Indication of procedure
Variceal screening 40 (28.2)
Abdominal pain 27 (19.0)
History of upper gastrointestinal
hemorrhage 16 (11.3)
Chronic vomiting 10 (7.0)
Anemia 9 (6.3)
Others 40 (28.2)
Type of intervention
Diagnostic procedure 99 (69.7)
Therapeutic procedure 43 (30.3)
Variceal banding 24 (16.9)
Sclerosing injection 16 (11.3)
Esophageal dilatation 2 (1.4)
Remove foreign body 1 (0.7)
and 7-month old. They were then intubated. After the
patient’s status had improved, the procedure was completed
with GA.
Table 3 showed the sedation related-complications com-
paring ASA physical status groups. Overall, 36 patients
(25.4%) experienced sedation related complications. Res-
piratory complications with hypoxia occurred in seven
patients (4.9%), and upper airway obstruction occurred in
six patients (4.2%). Cardiovascular complications arose in
23 patients (16.2%) and mainly consisted of hypotension
(14 patients) and bradycardia (9 patients). If only serious
complications are included, the complication rate is none.
All complications were easily treated and managed with
medication and/or maintenance of the patient’s airway by
thestaﬀanesthesiologistoranestheticpersonnelunderdirect
supervision of a staﬀ anesthesiologist who was physically
presentin theroom.Therewasnodiﬀerencein theincidence
ofcomplicationswhensedatedbytrainees,anestheticnurses,
or anesthesiologist.
The overall complications in children who had ASA
physical status I-II as compared to ASA physical status III-
IV were not signiﬁcantly diﬀerent (P = .202). Similarly the
respiratory and cardiovascular complications between these
two groups were not statistically diﬀerent. In addition, one
patient in ASA physical status I-II and one patient in ASA
physical status III-IV developed hypoxia and hypotension.
Two patients in ASA physical status I-II and one patient
in ASA physical status III-IV developed upper airway
obstruction and bradycardia. The emergence reactions or
hallucinations, increased salivation or laryngospasm were
not seen in patients receiving ketamine as part of IVS.
4. Discussion
This retrospective study demonstrates the clinical eﬀective-
ness of an anesthesiologist-administered intravenous seda-
tion outside of the main operating room for pediatric upper
gastrointestinal endoscopy in a developing country. The
complication rate of our study is relatively high. However,
the serious complications were none. IVS for pediatric
UGIE procedure in children 12 years of age and younger
is challenge and requires an experienced anesthesiologist as
well as appropriate monitoring. Anesthetic personnel should
remind themselves to use more sensitive equipments to
detect potential complication such as end tidal CO2 and
carefully select more appropriate patients.
UGIE procedure in children is an important and eﬀective
tool for the diagnosis and treatment of upper digestive
tract diseases. The indications for upper endoscopy in the
pediatric age group are similar to those for adult endoscopy
[8] .T h e s ep r o c e d u r e sa r eg e n e r a l l yp e r f o r m e de i t h e rw i t h
IVS in the endoscopy room, or under GA in the operating
room [9]. The decision to use GA is usually based on
the patients’ parameters such as age, diagnosis, respiratory
compromise and severity of disease. In some centers, GA
is used on all infants, children and adolescents [3, 10, 11].
However, in other centers, IVS is used for the procedures.
With IVS, several medication combinations have been used
successfully [9, 12–15].
In a developing country where pediatric UGIE per-
formed at increasing rates, the majority of cases are per-
formed under general anesthesia in the operating room
(OR). At Siriraj Hospital, there is a dedicated endoscopy unit
with dedicated anesthesia service. Over the last two years,
2006 to 2008, we performed most pediatric UGIE with IVS
[5–7]. We followed the guidelines provided by the American
Academy of Pediatrics and American Academy of Pediatric
Dentistry and ASA standards for sedation providers [4, 16].
Our previous reviews of IVS practice in pediatric population
showed that it can be done safely with various sedative
combinations with proper monitoring and anesthesiology
service supervision.
Majority of children received propofol in combination
with other sedatives. Propofol has gained wide acceptance
among adult gastroenterologist. Its use in pediatric popula-
tion has been shown to be safe, eﬀective and reliable [10–
15]. In Thailand, sedation with propofol is administered by
anesthesiologist. The drug combination provides synergistic
action while lowering the doses of each agent. Our practice
reﬂects this where many diﬀerent combination regimens
were used [5–7]. Propofol is the most common agent used
in combination with midazolam and fentanyl in this study.
Additionally, we did not observe hemodynamic instability,
emergence reactions, hallucinations, increased salivation or
laryngospasm with the use of ketamine combining regimen.
This observation was similar in the previous studies [17–19].4 International Journal of Pediatrics
Table 2: Intravenous sedative agents used by age and ASA physical status.
0–2.99 yr 3–9.99 yr >9.99 yr P-value ASA I-II ASA III-IV P-value
(20) (74) (48) (90) (52)
Propofol .032(a) .365
n (%) 19 (95.0) 72 (97.3) 46 (95.8) 88 (97.8) 49 (94.2)
mg/kg (mean, SD) 2.28 (2.29) 3.50 (2.99) 4.43 (3.36) 3.65 (3.44) 3.63 (2.37)
Fentanyl .896 .276
n (%) 12 (60.0) 64 (86.5) 42 (87.5) 76 (84.4) 42 (80.8)
mcg/kg (SD, range) 0.96 (0.16) 0.95 (0.20) 0.97 (0.27) 0.96 (0.21) 0.96 (0.25)
Midazolam .657 .578
n (%) 17 (85.0) 57 (77.0) 38 (79.2) 68 (75.6) 44 (84.6)
mg/kg (SD, range) 0.05 (0.05) 0.06 (0.07) 0.06 (0.04) 0.06 (0.06) 0.06 (0.04)
Ketamine .082 .564
n (%) 15 (75.0) 29 (39.2) 8 (16.7) 29 (32.2) 23 (44.2)
mg/kg (SD, range) 2.68 (4.44) 1.05 (0.24) 0.85 (0.33) 1.10 (0.35) 1.98 (3.66)
(a)considered statistically signiﬁcant.
Table 3: Complications comparing ASA physical status groups.
Complications ASA I-II (90) ASA III-IV (52) P-value
(36) n (%) n (%)
Overall 26 (28.9) 10 (19.2) .202
Respiratory 10 (11.1) 3 (5.8) .288
Hypoxia 5 (5.6) 2 (3.8) .650
(SpO2 < 90%)
Upper airway 5 (5.6) 1 (1.9) .300
Obstruction
Cardiovascular 16 (17.8) 7 (13.5) .501
Hypotension 9 (10.0) 5 (9.6) .941
Bradycardia 7 (7.8) 2 (3.8) .354
Cardiopulmonary complications account for more than
half of the major complications during endoscopy, and are
often related to hypoxia, especially in children less than 1
year old [20, 21]. In our study, the overall adverse event
was relatively high (25.4%). Cardiovascular complications
accounted for the majority (16.2%) followed by respiratory
complications (9.2%). However, all complications were
transient and easily treated with no adverse sequelae. Many
previous studies involving the use of propofol and other
combination sedative drugs have reported slightly higher
adverse events [22–24]. In our study, there was signiﬁcant
diﬀerence in the mean dose of propofol between the three
aged groups.
In a study by Barbi and colleagues, major desaturation
was noted in 0.7% of all the children, and transient
desaturation that resolved sponstaneously occurred in 12%
of all the procedures [22]. Additionally, the study by
Yildizdas ¸ et al. demonstrated that the use of propofol and
midazolam/fentanyl in 126 children had 16.6% incidence of
respiratory depression as shown by high end-tidal carbon
dioxide (>50 mmHg) [23]. The high incidence of respiratory
depression reﬂected the better detection of respiratory
depression by the use of end-tidal carbon dioxide. In our
study, complication rate is comparable to studies that did
not use end-tidal carbon dioxide monitoring [22, 24]. ASA
physical status III-IV has been shown to be a predictor of
increased risk for sedation-related complications [24]. There
is also a concern for increased respiratory complication
in patients undergoing UGIE procedures. Endoscope can
potentially compress and obstruct airway.
Several publications described the use of propofol for
sedation by physicians or providers other than anesthesi-
ologists [24–27]. Consequently, there was a diﬀerence in
outcomes once nonanesthesiologists use propofol. When
a dedicated pediatric sedation team involving an anes-
thesiologist was utilized, the reported successful sedation
rates were 100%, and adverse events ranged from 1.7 to
5% [28]. There was no failure of sedation in this study.
However, two patients became more deeply than intended
and required unplanned endotracheal intubation. Finally, all
procedures were completed as intended. A high success rate
in our study is due to the procedure is performed by an
experienced endoscopist and is sedated by an experienced
anesthesiologist. Consequently, our center had a dedicated
anesthesia service involved with sedation and the use of basic
noninvasive monitoring, which includes noninvasive bloodInternational Journal of Pediatrics 5
pressuremonitoring,pulseoximetry,andelectrocardiogram.
Additionally, the safe and successful sedation is also depen-
dent on proper preparation, evaluation, monitoring, and
appropriate skills to rescue the patient, and proper recovery
[27].
Our study has several limitations. This is a retrospective
paper of a cohort of patients undergoing pediatric UGIE
with IVS. We accept that there are limitations with chart
review in regards to proper and complete documentation.
We also realized that with this review, the study is reﬂected
in the variety of regimen and sedative drugs used for IVS. In
addition our cohort varied widely in age range. Therefore,
the drug requirement, drug doses, and side eﬀects varied
as well. According to the design of study, we deﬁned an
alteration of blood pressure by 20% from baseline, and
a decrease in heart rate by 30% from baseline as the
complication. The complication rate in this paper was also
relatively high. Moreover, we did not use the end tidal CO2
monitoring. Overall, even with these limitations, we believe
that the study ﬁndings are applicable to the sedation practice
and to remind the physicians for sedation the pediatric
patients for UGIE procedures.
In summary, this study shows the clinical eﬀectiveness
of an anesthesiologist-administered intravenous sedation
outside of the main operating room for pediatric upper gas-
trointestinal endoscopy in a developing country. Although,
the complication rate of our study is relatively high. All
complications were transient and easily treated with no
adverse sequelae. We also recommend the use of more
sensitiveequipmentstodetectpotentialcomplicationsuchas
end tidal CO2 and carefully select more appropriate patients
for pediatric UGIE.
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